Serveur d'exploration sur l'Indium - Analysis (France)

Index « Auteurs » - entrée « Robert M Sharkey »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

List of bibliographic references

Number of relevant bibliographic references: 3

.
Ident.Authors (with country if any)Title
000023 (2012) Pierre-Yves Salaun (France) ; Loïc Campion ; Claire Bournaud ; Alain Faivre-Chauvet ; Jean-Philippe Vuillez ; David Taieb ; Catherine Ansquer ; Caroline Rousseau ; Françoise Borson-Chazot ; Stéphane Bardet ; Aurore Oudoux ; Bertrand Cariou ; Eric Mirallié ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques Barbet ; Françoise Kraeber-BodéréPhase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
000095 (2006) Jean-François Chatal (France) ; Loïc Campion ; Françoise Kraeber-Bodéré ; Stephane Bardet ; Jean-Philippe Vuillez ; Bernard Charbonnel ; Vincent Rohmer ; Chien-Hsing Chang ; Robert M Sharkey ; David M Goldenberg ; Jacques Barbet ; Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group.
000129 (2003) Françoise Kraeber-Bodéré (France) ; Alain Faivre-Chauvet ; Ludovic Ferrer ; Jean-Philippe Vuillez ; Pierre-Yves Brard ; Caroline Rousseau ; Isabelle Resche ; Anne Devillers ; Sophie Laffont ; Manuel Bardiès ; Ken Chang ; Robert M Sharkey ; David M Goldenberg ; Jean-François Chatal ; Jacques BarbetPharmacokinetics and dosimetry studies for optimization of anti-carcinoembryonic antigen x anti-hapten bispecific antibody-mediated pretargeting of Iodine-131-labeled hapten in a phase I radioimmunotherapy trial.

List of associated KwdEn.i

Nombre de
documents
Descripteur
3Humans
3Radioimmunotherapy (methods)
2Adult
2Aged
2Male
2Middle Aged
2Neoplasm Metastasis
2Survival Analysis
2Thyroid Neoplasms (radiotherapy)
1Aged, 80 and over
1Animals
1Antibodies, Bispecific (adverse effects)
1Antibodies, Bispecific (chemistry)
1Antibodies, Bispecific (pharmacokinetics)
1Antibodies, Bispecific (therapeutic use)
1Antibodies, Monoclonal (therapeutic use)
1Antibodies, Monoclonal, Humanized (adverse effects)
1Antibodies, Monoclonal, Humanized (therapeutic use)
1Bone Marrow (pathology)
1Calcitonin (blood)
1Carcinoembryonic Antigen (chemistry)
1Carcinoembryonic Antigen (immunology)
1Disease Progression
1Female
1Haptens (chemistry)
1Indium (therapeutic use)
1Iodine Radioisotopes (therapeutic use)
1Mice
1Neoplasms (therapy)
1Pentetic Acid
1Pentetic Acid (immunology)
1Prognosis
1Quality Control
1Radioimmunotherapy (adverse effects)
1Radiometry
1Thyroid Neoplasms (metabolism)
1Thyroid Neoplasms (mortality)
1Thyroid Neoplasms (pathology)
1Time Factors
1Tissue Distribution
1Treatment Outcome
1Tumor Markers, Biological (metabolism)
1Young Adult

Affichage en shell (Unix/Dilib)

IndexSelect -h IndiumV2/Data/France/Analysis/Author.i -k "Robert M Sharkey" 
IndexSelect -h IndiumV2/Data/France/Analysis/Author.i  \
                -Sk "Robert M Sharkey" \
         | HfdSelect -Kh IndiumV2/Data/France/Analysis/biblio.hfd 

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Tue May 20 08:20:52 2014